Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients

P Mumby, W Adams, S Smith, M Rao, P Stiff - Transplantation and Cellular …, 2024 - Elsevier
Depression and decreased quality of life (QoL) develop in approximately 30% of
nondepressed hematopoietic stem cell transplantation (HSCT) recipients early after …
相关文章

Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients

P Mumby, W Adams, S Smith, M Rao… - … and Cellular Therapy …, 2024 - astctjournal.org
Depression and decreased quality of life (QoL) develop in approximately 30% of
nondepressed hematopoietic stem cell transplantation (HSCT) recipients early after …

Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients

P Mumby, W Adams, S Smith… - … and cellular therapy, 2024 - pubmed.ncbi.nlm.nih.gov
Depression and decreased quality of life (QoL) develop in approximately 30% of
nondepressed hematopoietic stem cell transplantation (HSCT) recipients early after …

Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplant Patients.

P Mumby, W Adams, S Smith, M Rao… - … and Cellular Therapy, 2023 - europepmc.org
Background Depression and decreased quality of life (QOL) develop in approximately 30%
of non-depressed hematopoietic stem cell transplant (HSCT) patients early after transplant …